Recent Posts
- Glyx Therapeutics to Attend BioFIT 2025 in Strasbourg
- Glyx Therapeutics to Participate in the 6th Trinational HealthTech Days
- Glyx Therapeutics to Attend Deeptech Connect 2025 in Paris
- HAS Refuses Early Access to Lecanemab in France: What It Means for Tau-Directed Innovation
- Marking World Alzheimer’s Day: Advancing the Fight Against Tauopathies
Recent Comments
No comments to show.
About Author

At Glyx Theapeutics, we believe in the power of collaboration, innovation, and continuous growth – both for patients and ourselves.



